Omeros (OMER) EBITDA Margin Growth (5y) (2015 - 2026)
Omeros (OMER) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Omeros |
737.87 Mn |
602.55 Mn |
9.31 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-948.00 |
| Sep 30, 2021 |
4,801.00 |
| Jun 30, 2021 |
2,687.00 |
| Mar 31, 2021 |
11,023.00 |
| Dec 31, 2020 |
-5,356.00 |
| Sep 30, 2020 |
46,397.00 |
| Jun 30, 2020 |
27,730.00 |
| Mar 31, 2020 |
468,826.00 |
| Dec 31, 2019 |
1.14 Mn |
| Sep 30, 2019 |
850,888.00 |
| Jun 30, 2019 |
3.99 Mn |
| Mar 31, 2019 |
1.65 Mn |
| Dec 31, 2018 |
98,483.00 |
| Sep 30, 2018 |
621,993.00 |
| Jun 30, 2018 |
767,256.00 |
| Mar 31, 2018 |
-93,467.00 |
| Dec 31, 2017 |
36,828.00 |
| Sep 30, 2017 |
90,236.00 |
| Jun 30, 2017 |
47,585.00 |
| Mar 31, 2017 |
47,148.00 |
